Objective and Subjective Upper Body Function Six Months Following Diagnosis of Breast Cancer Sandi HayesDiana BattistuttaBeth Newman Report Pages: 1 - 10
Quantitation of HDAC1 mRNA Expression in Invasive Carcinoma of the Breast* Zhenhuan ZhangHiroko YamashitaHirotaka Iwase Report Pages: 11 - 16
Assessment of Breast Cancer Tumor Size Depends on Method, Histopathology and Tumor Size Itself* K. HeusingerC. LöhbergP. A. Fasching Report Pages: 17 - 23
Synuclein Gamma Inhibits the Mitotic Checkpoint Function and Promotes Chromosomal Instability of Breast Cancer Cells Satoru InabaCong LiJingwen Liu Report Pages: 25 - 35
Nordihydroguaiaretic Acid (NDGA) Inhibits the IGF-1 and c-erbB2/HER2/neu Receptors and Suppresses Growth in Breast Cancer Cells Jack F. YoungrenKarissa GableIra D. Goldfine Report Pages: 37 - 46
Celecoxib Inhibits Urokinase-Type Plasminogen Activator (uPA) Production in MDA-MB-231 Breast Cancer Cells Heather N. AndrewsGolerah HabibiSandra E. Dunn Report Pages: 47 - 52
Electrophysiological Correlates of Information Processing in Breast-Cancer Patients Treated With Adjuvant Chemotherapy Baudewijntje P. C. KreukelsSanne B. SchagenFrits S. A. M. van Dam Report Pages: 53 - 61
Modifying Effects of Sulfotransferase 1A1 Gene Polymorphism on the Association of Breast Cancer Risk with Body Mass Index or Endogenous Steroid Hormones Gong YangYu-Tang GaoWei Zheng Epidemiology Pages: 63 - 70
Angiogenic Molecule Expression is Downregulated in Effusions from Breast Cancer Patients Sophya KonstantinovskySøren NielsenBen Davidson Report Pages: 71 - 80
Conversion of Fas-resistant to Fas-sensitive MCF-7 Breast Cancer Cells by the Synergistic Interaction of Interferon-γ and all-TransRetinoic Acid David N. DanforthYuelin Zhu Report Pages: 81 - 91
Topical Imiquimod to Treat Recurrent Breast Cancer Ulrich R. HenggeStephan RothAndrea Tannapfel Letter to the Editor Pages: 93 - 94